Atea Pharmaceuticals, Inc.
AVIR
17 insider filings · Latest: Jun 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 21 10:30 PM | Polly A. MurphyDirector | Purchase | 6,100 | $4.17 | $25.4K | 92,145(D) | View → |
| May 18, 2025 | May 20 8:15 PM | Polly A. MurphyDirector | Purchase | 6,100 | $4.17 | $25.4K | 92,145(D) | View → |
| Dec 10, 2024 | Dec 10 10:17 PM | Franklin Berger | Proposed Sale | 359,606 | $2.85 | $1.0M | — | View → |
| Sep 19, 2024 | Sep 19 8:22 PM | JPM Partners LLC | Proposed Sale | 1,841 | $4.00 | $7.4K | — | View → |
| Sep 18, 2024 | Sep 18 8:09 PM | JPM Partners LLC | Proposed Sale | 22,187 | $4.03 | $89.5K | — | View → |
| Sep 17, 2024 | Sep 17 8:16 PM | JPM Partners LLC | Proposed Sale | 33,941 | $4.05 | $137.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 23 9:00 PM | Bruno LucidiDirector | Grant/Award | 64,400 | $4.36 | 37,700(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Bruno LucidiDirector | Option Exercise | 29,600 | — | 0(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Franklin M BergerDirector | Option Exercise | 29,600 | — | 0(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Franklin M BergerDirector | Grant/Award | 64,400 | $4.36 | 37,700(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Berman HowardDirector | Grant/Award | 64,400 | $4.36 | 37,700(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Barbara Gayle DuncanDirector | Option Exercise | 29,600 | — | 0(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Barbara Gayle DuncanDirector | Grant/Award | 64,400 | $4.36 | 37,700(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Bruce PolskyDirector | Grant/Award | 64,400 | $4.36 | 37,700(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Bruce PolskyDirector | Option Exercise | 29,600 | — | 0(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Polly A. MurphyDirector | Option Exercise | 29,600 | — | 0(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Polly A. MurphyDirector | Grant/Award | 64,400 | $4.36 | 37,700(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Jerome M. AdamsDirector | Option Exercise | 29,600 | — | 0(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Jerome M. AdamsDirector | Grant/Award | 64,400 | $4.36 | 37,700(D) | View → |
| Jun 18, 2026 | Jun 23 9:00 PM | Arthur S KirschDirector | Grant/Award | 64,400 | $4.36 | 37,700(D) | View → |
| Mar 11, 2026 | Mar 13 10:00 PM | Andrea CorcoranChief Financial Officer, Executive Vice President, Legal and Secretary | Option Exercise | 60,000 | $1.24 | 0(D) | View → |
| Jan 31, 2026 | Feb 4 12:53 AM | Maria Arantxa HorgaChief Medical Officer | Option Exercise | 51,283 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 4 12:53 AM | Maria Arantxa HorgaChief Medical Officer | Grant/Award | 173,500 | $4.24 | 173,500(D) | View → |
| Jan 31, 2026 | Feb 4 12:47 AM | John VavrickaChief Commercial Officer | Option Exercise | 42,083 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 4 12:47 AM | John VavrickaChief Commercial Officer | Grant/Award | 119,520 | $4.24 | 119,520(D) | View → |
| Jan 31, 2026 | Feb 4 12:46 AM | Janet MJ HammondChief Development Officer | Grant/Award | 177,000 | $4.24 | 177,000(D) | View → |
Page 1 of 2
Next →